Integrating multimorbidity into a whole-body understanding of disease using spatial genomics
A dosing review does not automatically mean going back to your highest dose
Our innovative semaglutide program combines cutting-edge medical interventions with a sustainable approach to weight management
Fusion, which supports mitochondrial complementation under stress, is regulated by optic atrophy type 1 (Opa1) and mitofusins (Mfn1/2) on the inner and outer mitochondrial membranes
Clinical Evidence: Blood Pressure Reductions in GLP-1 Trials The LEADER trial, which followed over 9,000 people taking liraglutide (a similar GLP-1 drug), documented average systolic blood pressure drops of 23 mmHg within the first weeks of treatment
While there is mechanistic support for this (different receptor occupancy thresholds), it has not been definitively demonstrated in human studies